Cite

HARVARD Citation

    Macchini, M. et al. (2021). Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants. Cancer treatment reviews. p. . [Online]. 
  
Back to record